Enveric Biosciences Inc (ENVB)
$0.83
Insights on Enveric Biosciences Inc
Vs NVO
In the last 1 year, Novo Nordisk A/s has given 58.5% return, outperforming this stock by 130.5%
Vs NVO
In the last 3 years, Novo Nordisk A/s has given 232.5% return, outperforming this stock by 331.9%
Performance
- $0.80$0.84$0.83
3.6%
Downside
Day's Volatility :5.2%
Upside
1.66%
- $0.65$6.98$0.83
21.81%
Downside
52 Weeks Volatility :90.7%
Upside
88.11%
Returns
| Period | Enveric Biosciences Inc | Index (Russel 2000) |
|---|---|---|
3 Months | -2.59% | 0.0% |
6 Months | -40.87% | 0.0% |
1 Year | -72.03% | 0.0% |
3 Years | -99.34% | -20.1% |
Highlights
Market Capitalization | 6.4M |
Book Value | $0.71 |
Earnings Per Share (EPS) | -8.09 |
Wall Street Target Price | 8.0 |
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | -86.2% |
Return On Equity TTM | -197.47% |
Revenue TTM | 35.4M |
Revenue Per Share TTM | 37.68 |
Quarterly Revenue Growth YOY | -7.3% |
Gross Profit TTM | 8.2M |
EBITDA | -16.1M |
Diluted Eps TTM | -8.09 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -2.66 |
EPS Estimate Next Year | -1.41 |
EPS Estimate Current Quarter | -0.77 |
EPS Estimate Next Quarter | -0.53 |
Analyst Recommendation
- Current
- 1M Ago
- 3M Ago
Analyst Forecast
What analysts predicted
Upside of 863.86%
Technicals Summary
Sell
Neutral
Buy
Enveric Biosciences Inc is currently in a neutral trading position according to technical analysis indicators.
Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
 Enveric Biosciences Inc | -3.83% | -40.87% | -72.03% | -99.34% | -99.61% |
 Moderna, Inc. | 37.56% | 83.82% | 13.37% | -12.47% | 553.14% |
 Regeneron Pharmaceuticals, Inc. | 10.42% | 24.29% | 32.26% | 98.6% | 210.52% |
 Novo Nordisk A/s | 7.9% | 30.89% | 58.53% | 230.87% | 458.51% |
 Vertex Pharmaceuticals Incorporated | 10.52% | 25.13% | 30.01% | 109.26% | 156.43% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
Enveric Biosciences Inc | NA | NA | NA | -2.66 | -1.97 | -0.86 | NA | 0.71 |
Moderna, Inc. | 24.73 | NA | 0.0 | -6.46 | -0.38 | -0.16 | NA | 33.47 |
Regeneron Pharmaceuticals, Inc. | 29.16 | 29.16 | 1.46 | 44.2 | 0.15 | 0.08 | NA | 250.15 |
Novo Nordisk A/s | 45.83 | 45.83 | 2.36 | 3.5 | 1.0 | 0.25 | 0.01 | 22.18 |
Vertex Pharmaceuticals Incorporated | 28.9 | 28.9 | 0.53 | 17.11 | 0.24 | 0.13 | NA | 71.8 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
Enveric Biosciences Inc | Buy | $6.4M | -99.61% | NA | 0.0% |
Moderna, Inc. | Buy | $54.0B | 553.14% | 24.73 | -115.82% |
Regeneron Pharmaceuticals, Inc. | Buy | $108.8B | 210.52% | 29.16 | 29.45% |
Novo Nordisk A/s | Buy | $592.1B | 458.51% | 45.83 | 36.55% |
Vertex Pharmaceuticals Incorporated | Buy | $115.1B | 156.43% | 28.9 | 39.46% |
Institutional Holdings
Armistice Capital, LLC
3.74%AdvisorShares Investments, LLC
1.94%BlackRock Inc
0.41%Vanguard Group Inc
0.25%Geode Capital Management, LLC
0.18%Tower Research Capital LLC
0.17%
Company Information
ameri100 embodies a value system of ambition, mastery, excitement, reliability and integrity. with these values, the company is becoming an emerging global leader in sap technologies. ameri100, founded in 2013 has rapidly grown through strategic acquisitions. headquartered in princeton, new jersey, with offices in new york, georgia, kansas, pennsylvania, arizona, toronto- canada and bangalore, mumbai, chennai in india, ameri100 brings 500+ of its own best-in-class resources. the company has also evolved a unique partner ecosystem, which adds more than 4500+ resources to its delivery muscle power. ameri100 deals with sap enterprise services, digital transformation, cloud solutions, business intelligence & analytics, mobile applications and professional services. the company is also making strategic investments in artificial intelligence (ai), internet of things (iot) and robotic process automation (rpa). insight to impact!
Organization | Enveric Biosciences Inc |
Employees | 7 |
CEO | Dr. Joseph Edward Tucker Ph.D. |
Industry | Miscellaneous |
Discover More
A Spac I Acquisition Corp
$0.83
+0.24%
Keyarch Acquisition Corp
$0.83
+0.24%
Connexa Sports Technologies Inc
$0.83
+0.24%
Us Value Etf
$0.83
+0.24%
First Wave Biopharma Inc
$0.83
+0.24%
Global X Msci Next Emerging
$0.83
+0.24%
Fat Projects Acquisition Corp
$0.83
+0.24%
Ishares Intl Div Growth Etf
$0.83
+0.24%
Corsair Gaming, Inc.
$0.83
+0.24%